These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19341614)

  • 1. Cardiovascular regeneration: pushing and pulling on progenitors.
    Steinhauser ML; Lee RT
    Cell Stem Cell; 2009 Apr; 4(4):277-8. PubMed ID: 19341614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.
    Zaruba MM; Theiss HD; Vallaster M; Mehl U; Brunner S; David R; Fischer R; Krieg L; Hirsch E; Huber B; Nathan P; Israel L; Imhof A; Herbach N; Assmann G; Wanke R; Mueller-Hoecker J; Steinbeck G; Franz WM
    Cell Stem Cell; 2009 Apr; 4(4):313-23. PubMed ID: 19341621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
    Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM
    Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
    Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vildagliptin and G-CSF Improved Angiogenesis and Survival after Acute Myocardial Infarction.
    Li M; Wang Z; Xia H; Yu L; Hu Z
    Arch Med Res; 2019 Apr; 50(3):133-141. PubMed ID: 31495390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.
    Ghadge SK; Mühlstedt S; Ozcelik C; Bader M
    Pharmacol Ther; 2011 Jan; 129(1):97-108. PubMed ID: 20965212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.
    Huber BC; Brunner S; Segeth A; Nathan P; Fischer R; Zaruba MM; Vallaster M; Theiss HD; David R; Gerbitz A; Franz WM
    Cardiovasc Res; 2011 Jun; 90(3):529-37. PubMed ID: 21245057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.
    Brunner S; Winogradow J; Huber BC; Zaruba MM; Fischer R; David R; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
    FASEB J; 2009 Feb; 23(2):351-61. PubMed ID: 18827024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
    Petit I; Szyper-Kravitz M; Nagler A; Lahav M; Peled A; Habler L; Ponomaryov T; Taichman RS; Arenzana-Seisdedos F; Fujii N; Sandbank J; Zipori D; Lapidot T
    Nat Immunol; 2002 Jul; 3(7):687-94. PubMed ID: 12068293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction.
    Xue J; Du G; Shi J; Li Y; Yasutake M; Liu L; Li J; Kong Y; Wang S; Yun F; Li W
    Chin Med J (Engl); 2014; 127(9):1677-83. PubMed ID: 24791874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.
    Segers VF; Tokunou T; Higgins LJ; MacGillivray C; Gannon J; Lee RT
    Circulation; 2007 Oct; 116(15):1683-92. PubMed ID: 17875967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
    Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
    Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.
    Bendall LJ; Bradstock KF
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):355-67. PubMed ID: 25131807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?
    Marquez-Curtis L; Jalili A; Deiteren K; Shirvaikar N; Lambeir AM; Janowska-Wieczorek A
    Stem Cells; 2008 May; 26(5):1211-20. PubMed ID: 18292211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.
    Ratajczak MZ; Kucia M; Reca R; Majka M; Janowska-Wieczorek A; Ratajczak J
    Leukemia; 2004 Jan; 18(1):29-40. PubMed ID: 14586476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.
    Lévesque JP; Hendy J; Takamatsu Y; Simmons PJ; Bendall LJ
    J Clin Invest; 2003 Jan; 111(2):187-96. PubMed ID: 12531874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring stem cell mobilization to promote vascular repair in diabetes.
    Albiero M; Avogaro A; Fadini GP
    Vascul Pharmacol; 2013 Apr; 58(4):253-8. PubMed ID: 23369723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.